Skip to main content

JANE STREET GROUP, LLC

Position in INBX — Inhibrx Biosciences, Inc.

CIK 1595888 NEW YORK, NY

Position in INBX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$618,246 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
9 quarters on record

Common Shares in INBX Over Time

Shares Held

Position Value (USD)

Derivatives in INBX

reported options exposure · as of Jun 30, 2026
CallValue
$1,819,200
CallShares
19,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in INBX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,819,200 19,200
2026-03-31 $618,246 9,196
2026-03-31 $1,761,426 26,200
2025-12-31 $2,923,000 37,000
2025-12-31 $4,179,100 52,900
2025-12-31 $2,608,501 33,019
2025-09-30 $2,119,852 62,941
2025-06-30 $276,451 19,373
2025-03-31 $367,937 26,300
2024-12-31 $1,361,652 88,419
2024-09-30 $1,534,773 98,006
2024-06-30 $1,456,122 102,761